Azithromycin in the Treatment of Community-acquired Pneumonia in Children
We observed 31 children aged 6 months to 6 years with community-acquired pneumonia, treated as a causal treatment of azithromycin. 20 children treated Azitroks suspension, 11 children - Sumamed suspension (control group). Results of the study showed that the efficacy and safety of the drug Azitroks...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
LLC "Diagnostics and Vaccines",
2016-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | We observed 31 children aged 6 months to 6 years with community-acquired pneumonia, treated as a causal treatment of azithromycin. 20 children treated Azitroks suspension, 11 children - Sumamed suspension (control group). Results of the study showed that the efficacy and safety of the drug Azitroks suspension for the treatment of community-acquired pneumonia in children is comparable to the original drug Sumamed suspension that characterizes him as a quality domestic production of generic and can be recommended for wide use in pediatric patients. |
|---|---|
| Item Description: | 2072-8107 10.22627/2072-8107-2016-15-1-45-48 |